I know I said I'd get to this last week, but work (on the CLE conference I am at) got in the way. Anyway, I have had a chance to look at the OIG's 2010 Work Plan and there is a lot in it about home health. (Hospice is mentioned, but not nearly as much.)
OIG is going to look at a number of areas that have been of concern in the past, for example Part B payments to home health beneficiaries. OIG is concerned that outside suppliers of services and medical supplies may be receiving payments for services that are covered by a home health episodic payment.
OIG is also going to be looking at the accuracy of HHRG coding. THis should not be a huge surprise, given that CMS used coding creep to justify reductions in home health reimbursement under the revised PPS. If you are not auditing your HHRG coding to make sure it is accurate, you should start. The clinical record should support the codes you use. Not only is upcoding an problem for individual agencies (fraud, false claims, etc.), but if OIG sees a "trend", you can count on more reductions.
Not surprisingly, given what happened in Miami, OIG is going to be looking at home health payments for insulin injections. They will also be looking at outlier payments in general.
Perhaps the worst item in the work plan is OIG's announcement that it will be reviewing home health agency profitability. OIG intends to review cost report data to analyze HHA profitability trends. Of course, OIG is doing this to see if the payment methodology should be adjusted. OIG was led to add this to the work plan, because of the increasing home health expenditures since 2000. OIG does not make clear what level of profitability it will find to be acceptable. Given MedPAC's annual cry for rate reductions based upon the "profitability" of home health agencies, I would wager a large amount of money on how this one turns out.
This makes it all the more important for HHAs to get their cost reports correct. If OIG sees what it thinks are unacceptable profits, it will add its voice to MedPAC's cry to reduce excessive profitability by reducing rates. It won't matter if the assessment is based upon flawed cost report data. (For those of you who are home health compliance officers, you should consider adding cost reporting to this year's audit plan)
I also think it is suspect to have OIG assessing profitability. Compliance with legal standards is one thing, compliance with an ephemeral notion of profitability is another. This is an area to monitor closely, because it seems very likely that OIG will determine the "methodology needs to be adjusted" - translation - home health rates need to be cut.
Finally, OIG says it will be looking at home health Diabetes Self-Management Training Services. They are going to look at regions with billing patterns that show high utilization of these services. If you provide these services, you should check that all such patients meet the conditions of coverage, including the quality standards. OIG will also be reviewing CMS's oversight of HHA Oasis data. It looks like OIG will be focusing more on CMS' end of the OASIS chain, specifically CMS' process for ensuring HHAs submit accurate and complete OASIS data.
OIG will also look at Medicaid home health issues. One that you should be auditing for is services for which Medicare and Medicaid paid. OIG is going to look at data to determine the extent to which Medicare and Medicaid both paid for the same service. OIG will also look at what controls states have in place to prevent this. I suspect that, although they seem to be concerned about the state's controls, their look at the data might lead to agencies being contacted as well. (At a minimum, somebody owes the government a payback.) OIG will also be checking that Medicaid HHAs meet the requirements to provide services and whether the beneficiaries are eligible.
HOSPICE
Hospice does not receive as much attention in this year's work plan.
OIG is going to look at physician billing for Medicare beneficiaries. OIG is concerned that physicians are billing for services that are covered under the hospice benefit. They are looking for double billing by physicians. (If the physician is providing a covered service as an employee of or under arrangements with the hospice, the hospice is paid to provide the service. The physician should not bill separately.)
OIG is also going to evaluate utilization of the hospice benefit. They are looking at the increasing diagnoses that go onto hospice as well as the increase in lengths of stay since the 210 day cap was removed. OIG will also look at the characteristics of hospice beneficiaries, geographical variations, and differences between for-profit and not-for-profit hospices.
OIG is going to evaluate duplicate drug claims under the hospice benefit and part D. This was an area OIG mentioned last year as well. This is similar to the physician billing issue. OIG will be looking to see if Part D claims for drugs for hospice beneficiaries were covered under the hospice benefit. They will also be looking to see if Part D payments are correct, supported, and not duplicated payments. Finally, they will look to identify controls to prevent duplicate payments.